T1	Participants 176 215	pulmonary morbidity after rib fractures
T2	Participants 415 537	patients with rib fractures who received ketorolac <4 days after injury compared with a random sample of those who did not
T3	Participants 553 588	202 patients who received ketorolac
T4	Participants 593 609	417 who did not,
T5	Participants 66 80	rib fractures.
